Pfizer : PFE

All Pfizer Articles

1465 Articles

Trey Thoelcke | Jul 13, 2020 at 7:39 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Jon C. Ogg | Jul 9, 2020 at 10:59 AM EDT

5 Undervalued Defensive Stocks Not Receiving Enough Credit for a Post-Coronavirus Recovery

24/7 Wall St. has identified five defensive stocks that must greatly improve before they are deemed expensive or fully valued…

Chris Lange | Jul 8, 2020 at 10:52 AM EDT

Why Pfizer’s Stock Could Rise 60% or More

Pfizer is among the current frontrunners for a COVID-19 vaccine, so why is its stock down 13% year to date?…

Chris Lange | Jul 7, 2020 at 8:55 AM EDT

5 Speculative COVID-19 Stocks That Could Still Surge

24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a…

Chris Lange | Jul 1, 2020 at 12:53 PM EDT

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

Pfizer and BioNTech have been collaborating to produce a messenger RNA based vaccine for the past few months, and this…

Trey Thoelcke | Jun 25, 2020 at 6:15 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | Jun 10, 2020 at 6:55 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | May 28, 2020 at 7:20 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | May 12, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks. The…

Chris Lange | May 5, 2020 at 11:12 AM EDT

BioNTech and Pfizer Kick Off Human Trials for COVID-19 Vaccine

BioNTech and Pfizer stocks each made a handy gain on Monday after the companies announced the beginning of human trials…

Chris Lange | Apr 28, 2020 at 1:17 PM EDT

Why Pfizer and Merck Earnings Are Slowing the Dow

Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday. Although markets appear to be recovering,…

Chris Lange | Apr 27, 2020 at 12:13 PM EDT

What to Watch When Merck and Pfizer Report Tuesday Morning

Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.

Chris Lange | Apr 27, 2020 at 9:37 AM EDT

Big Pharma Short Sellers Can’t Make Up Their Minds

The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Apr 27, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Microsoft and Pfizer above all other Dow stocks.

Chris Lange | Apr 26, 2020 at 7:20 AM EDT

Apple, Exxon, Microsoft, Pfizer and More Dow Earnings Coming This Week

Over one-third of the Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. Here's…

1 … 20 21 22 23 24 … 98

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted Dow Stocks

5 Undervalued Defensive Stocks Not Receiving Enough Credit for a Post-Coronavirus Recovery

Why Pfizer’s Stock Could Rise 60% or More

5 Speculative COVID-19 Stocks That Could Still Surge

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

BioNTech and Pfizer Kick Off Human Trials for COVID-19 Vaccine

Why Pfizer and Merck Earnings Are Slowing the Dow

What to Watch When Merck and Pfizer Report Tuesday Morning

Big Pharma Short Sellers Can’t Make Up Their Minds

The 5 Most Shorted Dow Stocks

Apple, Exxon, Microsoft, Pfizer and More Dow Earnings Coming This Week

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted Dow Stocks

5 Undervalued Defensive Stocks Not Receiving Enough Credit for a Post-Coronavirus Recovery

Why Pfizer’s Stock Could Rise 60% or More

5 Speculative COVID-19 Stocks That Could Still Surge

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

BioNTech and Pfizer Kick Off Human Trials for COVID-19 Vaccine

Why Pfizer and Merck Earnings Are Slowing the Dow

What to Watch When Merck and Pfizer Report Tuesday Morning

Big Pharma Short Sellers Can’t Make Up Their Minds

The 5 Most Shorted Dow Stocks

Apple, Exxon, Microsoft, Pfizer and More Dow Earnings Coming This Week

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%